South Africa tightens rules on weight-loss drugs
Pharmaceutical giants Novo Nordisk and Eli Lilly have sought to curb the pharmacy-made products competing with their blockbuster GLP-1 drugs. South Africa is planning to tighten the rules around pharmacies making their own compound versions of medicines, including the popular weight-loss and diabetes treatments Ozempic